SE329165B - - Google Patents

Info

Publication number
SE329165B
SE329165B SE335065A SE335065A SE329165B SE 329165 B SE329165 B SE 329165B SE 335065 A SE335065 A SE 335065A SE 335065 A SE335065 A SE 335065A SE 329165 B SE329165 B SE 329165B
Authority
SE
Sweden
Application number
SE335065A
Inventor
T Takano
S Horibe
K Hattori
M Kurita
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE329165B publication Critical patent/SE329165B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
SE335065A 1964-03-14 1965-03-15 SE329165B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1427464 1964-03-14
JP4213164 1964-07-23

Publications (1)

Publication Number Publication Date
SE329165B true SE329165B (de) 1970-10-05

Family

ID=26350188

Family Applications (1)

Application Number Title Priority Date Filing Date
SE335065A SE329165B (de) 1964-03-14 1965-03-15

Country Status (3)

Country Link
FR (1) FR5564M (de)
GB (1) GB1038529A (de)
SE (1) SE329165B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0639474B2 (ja) * 1983-03-04 1994-05-25 大塚化学株式会社 セファロスポリン化合物の製造法
DE3687200T2 (de) * 1985-09-03 1993-05-27 Otsuka Kagaku Kk Cephalosporinderivate.
AT405283B (de) 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
KR20050087776A (ko) 2002-08-13 2005-08-31 산도즈 아게 세프디니르 중간체

Also Published As

Publication number Publication date
GB1038529A (en) 1966-08-10
DE1545794A1 (de) 1969-12-11
DE1545794B2 (de) 1975-07-31
FR5564M (de) 1968-01-02

Similar Documents

Publication Publication Date Title
BE659264A (de)
BE661165A (de)
BE432268A (de)
BE47396A (de)
BE483969A (de)
BE507097A (de)
BE518974A (de)
BE554195A (de)
BE564626A (de)
BE584699A (de)
BE603534A (de)
BE610935A (de)
BE613833A (de)
BE621510A (de)
BE622126A (de)
BE623398A (de)
BE626083A (de)
BE626684A (de)
BE627057A (de)
BE627390A (de)
BE627931A (de)
BE628611A (de)
BE629793A (de)
BE632875A (de)
BE636791A (de)